Don't Use Medical Marijuana for Sleep Apnea, AASM Warns

Medical cannabis and synthetic marijuana extracts should not be used to treat obstructive sleep apnea (OSA), the American Academy of Sleep Medicine (AASM) has advised in a position statement.

In November 2017, the Minnesota State Department of Health (MDH) added OSA  to the state’s list of qualifying conditions for use of medical cannabis.

However, on the basis of currently available evidence, the AASM has concluded that medical cannabis and/or its synthetic extracts should not be used for the treatment of OSA because of unreliable delivery methods and a lack of sufficient evidence of effectiveness, tolerability, and safety.  It is their position that OSA should be excluded from the list of chronic medical conditions for state medical cannabis programs.

The AASM position statement on medical cannabis for treatment of OSA is published in the April 15 issue of the Journal of Clinical Sleep Medicine.  

Health Department Misstep

The MDH decided to authorize medical marijuana for the treatment of OSA “despite very limited evidence on its efficacy published to date,” lead author, Kannan Ramar, MD, told Medscape Medical News.

This prompted the AASM Board of Directors to “approve the development of this position statement paper to recommend that medical cannabis and/or its synthetic extracts not be used to treat OSA until further evidence is available,” said Ramar, professor of medicine, Division of Pulmonary and Critical Care Medicine, Center for Sleep Medicine, Mayo Clinic, Rochester, Minnesota.

“[P]atients should discuss proven treatment options with a licensed medical provider at an accredited sleep facility,” said Ramar.

Scott Smith, public information officer for MDH, told Medscape Medical News that “Minnesota’s medical cannabis program relies on clinicians to use their best medical judgement to determine whether medical cannabis is the correct choice for their patients, regardless of which of the approved conditions they are seeking to

Read More Here...

First 9 medical marijuana businesses OK'd toward licensure in Michigan

LANSING — Michigan regulators have allowed the first marijuana businesses to start the process toward being licensed to operate in the newly regulated and taxed industry.

The Medical Marihuana Licensing Board took the first step Thursday toward qualifying the applications of nine businesses and turned down two. The applicants need physical locations and community approval to proceed.

Initial licenses to grow, process, sell, transport or test marijuana will be issued by June 15. Some have expressed concerns the process isn’t moving quickly enough.

The state began accepting applications in December and 470 individuals or companies have applied.

A 2016 law aimed to address confusion surrounding the legality of dispensary shops that opened after voters in 2008 authorized marijuana for medical use. The new law includes a 3 percent tax on provisioning centers.

According to The Detroit News, pre-approved applicants include three Ann Arbor businesses owned by James Daly and Brian Doelle, who are seeking licensure to grow up to 500 marijuana plants through a company called Arbor Farms, process the drug at Arbor Kitchen and sell to patients at a Cannarbor dispensary less than a half-mile from the University of Michigan.

Other metro Detroit business pre-approved Thursday include a planned ABKO Labs safety testing facility in Troy; Motas Inc., a secure transporter based in Hazel Park; an Herben Legends dispensary in Southfield; and a Pure Green processing facility in Inkster, The News reported.

The others were in Portage and Muskegon.

Read More Here...

Medical marijuana bill advances out of committee in SC House

click to enlarge Photo illustration by Scott Suchy A bill that would widen the pool of patients eligible for medical marijuana products in South Carolina is ready for debate in the State House after getting the approval of a medical committee Thursday morning.

The Medical, Military, Public and Municipal Affairs Committee approved H. 3521, also known as the “S.C. Compassionate Care Act,” in a 14-3 vote.

The bill would allow doctors to prescribe patients suffering from certain conditions with medical marijuana and marijuana-infused products. The allowed “debilitating” conditions include cancer, glaucoma, HIV, Hepatitis C, Crohn’s disease, PTSD, autism, Parkinson’s disease, and Alzheimer’s, as well as any condition causing debilitating pain, severe nausea, and seizures.

The Senate Medical Affairs Committee approved a similar bill on an 8-6 vote last month, according to the Associated Press. In 2014, lawmakers passed a bill allowing for the treatment of epilepsy with non-psychoactive cannabidiol products, which are derived from the cannabis plant, within clinical trials.

Under the law, an “allowable amount of medical cannabis” is defined as two ounces.

Patients would need to obtain a valid registry card from the S.C. Department of Health and Environmental Control.

The bi-partisan bill was introduced in January and is sponsored by 24 members of the House, including five— Reps. Gilliard, McCoy, Stavrinakis, Mace, and Bennett—from the Charleston area.

“I believe we did the right thing by approving this bill,” said committee chair Rep. Leon Howard (D-Columbia) in a statement. “Our intent is to help the thousands of patients who can benefit from this medical treatment, including retired military personnel and children who suffer from debilitating illnesses.”

Howard warned that the road ahead for a medical marijuana bill in S.C. remains rocky.

“I want supporters of the bill to understand that it is highly unlikely that this bill or any other medical cannabis bill becomes law

Read More Here...

Medical marijuana reform bill advances

A bill to reform the state’s medical marijuana program appeared headed to Gov. Paul LePage on Wednesday.

The second major piece of cannabis legislation to pass both houses of the Legislature in as many days would expand the number of people who can qualify for a medical marijuana card, increase the number of state-licensed dispensaries and allow registered caregivers to see more patients, hire more workers and run storefront operations without the threat of legal reprisal. LePage has 10 days to act on the bill once it lands on his desk, although its supporters expect him to veto it.

The status of the bill and whether it needs additional enactment votes was unclear early Thursday, as lawmakers worked late into the night debating whether to extend the session. Enactment votes are procedural actions taken before a bill can advance to the governor.

The Senate voted 25-10 in favor of the bill on Wednesday. The proposal was approved by the House with ease on Friday, without debate or even a roll call.

“Years back, when I first encountered the idea of medical marijuana, I thought it was a joke … just some clever excuse used to try to get to adult-use marijuana, but I was wrong,” said Sen. Eric Brakey, R-Auburn, co-chair of the legislative committee that spent months crafting the bill. “My fiancée is a medical cannabis patient. … She suffered with intractable pain for much of her life. I have personally seen how access to this medicine has helped her.”



This legislative reform has been more than two years in the making, delayed while lawmakers waited to see what would happen to the recreational marijuana bill. After waiting for 18 months, the committee decided it had to push through an omnibus bill

Read More Here...

Medical Marijuana, Inc.'s CBD Products Discounted in Celebration of Cannabis Culture Holiday 4/20

SAN DIEGO, April 19, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that it is excited to celebrate cannabis culture’s national holiday, 4/20, with exciting product discounts.

Over the years, 4/20 has evolved into a cultural experience that extends much further than just a designated day for stoners to get “high.” For many people in the U.S., it has become a day of recognition and pride of how far the cannabis industry has come since prohibition and the many legislative and research accomplishments of the past decade.

On April 20, 2018, Medical Marijuana, Inc. celebrates the 4/20 holiday with the best discounts of the year on its CBD product brands Real Scientific Hemp Oil™, Dixie Botanicals®, Cibdex® and Cibaderm®. A wide selection of our best-selling CBD products will be discounted up to 50% off.

“We are excited to be able to applaud the dedication and hard work of cannabis advocates across the nation and our loyal customers with these generous discounts,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Yesterday’s stoner holiday is today’s celebration of increased access to the entire cannabis plant, hemp and marijuana, and the leaps and bounds the industry continues to make year after year.”

Real Scientific Hemp Oil™ (RSHO™) is the company’s flagship product brand. It is a pure non-GMO hemp oil, unmodified and sourced straight from the hemp plant. RSHO™ is extracted from hemp using supercritical CO2 and Triple Lab Tested™ and is cultivated free of chemical fertilizers, pesticides or herbicides in Northern Europe. 

The company’s Dixie Botanicals® brand is well-known for its delicious edibles and tinctures. Dixie Botanicals® Dew Drops are a great way to take cannabidiol (CBD) because they’re naturally sweetened with flavors such as cinnamon

Read More Here...